Scientific Day 2025

Watch the replays and discover Epicentre's latest studies!

Discover our current projects

on Ebola, COVID19, HIV, tuberculosis, malaria, Lassa fever, cholera, nutrition...

Our mission

Field epidemiology, research projects and training sessions in support of MSF.

Measle

An update on the latest studies conducted by Epicentre to combat this infectious disease
Field epidemiology activities, research projects and training sessions in support of Médecins sans frontières
Field epidemiology activities, research projects and training sessions in support of Médecins sans frontières

Latest news

Bannière
DRC ©Newsha Tavakolian
News

Why sex, gender and pregnancy data are essential in times of epidemics?

Published on 20.01.2025
Bannière
Hepatitis E Bentiu, South Sudan
News

Hepatitis E Vaccine: Efficacy of a two-dose regimen and safety for pregnant women confirmed by real-life study

Published on 10.01.2025
Bannière
CAD Tuberculose Philipinnes
News

Enhancing Tuberculosis Diagnosis with AI: Insights from a Study in Manila, Philippines

Published on 17.12.2024

Latest publications

Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysis.

The Lancet Child & Adolescent Health. Volume 9, Issue 2, February 2025, Pages 100-111. doi: 10.1016/S2352-4642(24)00330-4
Published on

Beyond COVID-19, the case for collecting, analysing and using sex-disaggregated data and gendered data to inform outbreak response: a scoping review.

BMJ global health 2025 Jan 19; 10(1); . doi: 10.1136/bmjgh-2024-015900. Epub 2025 01 19
Published on

Effect of mass campaigns with full and fractional doses of pneumococcal conjugate vaccine (Pneumosil) on the reduction of nasopharyngeal pneumococcal carriage in Niger: a three-arm, open-label, cluster-randomised trial.

The Lancet. Infectious diseases 2025 Jan 08; . doi: 10.1016/S1473-3099(24)00719-9. Epub 2025 01 08
Published on

The effectiveness of two doses of recombinant hepatitis E vaccine in response to an outbreak in Bentiu, South Sudan: a case-control and bias indicator study.

The Lancet. Infectious diseases 2025 Jan 08; . doi: 10.1016/S1473-3099(24)00657-1. Epub 2025 01 08
Published on

Discover our training courses

Transmitting and transferring epidemiological knowledge is an integral part of Epicentre's mission. Training courses are provided throughout the year to MSF staff and beyond.